MADRID, Spain—Ten years after experiencing STEMI complicated by cardiogenic shock, patients treated with the Impella CP device (Abiomed) continue to have a survival advantage over those receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback